LINK ALTERNATIF MBL77 SECRETS

Not all sufferers with CLL involve therapy. Irrespective of all recent innovations, the iwCLL however recommends watchful observation for patients with asymptomatic ailment.86 This suggestion relies on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104